Clinical-Risk Factors that Influence an Optimal Hypomethylating Agents Treatment in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia. (April 2017)

• Record Type: Journal Article
• Authors: Iastrebner, M.; Lazzarino, C.; Nucifora, E.; Penchasky, D.; Fernandez, I.; Gusmao Moreno, B.G.M.; Rivas, M.M.; Espinosa, D.; Abello Polo, V.; Boada, M.; Enrico, A.; Araujo Schuster, S.; Agra, M.; Sarmiento, M.; Flores, G.; Alfonso, G.; Crisp, R.; Gusmao Moreno, B.; Consortium, I.
• Is Part Of: Leukemia research. Volume 55(2017)Supplement 1
• Page Start: S64
• Publication Date: 2017-04
• Subjects: Leukemia -- Periodicals; Leukemia -- Periodicals; Leucémie -- Périodiques; Leukemia; Periodicals; Electronic journals; Electronic journals; 616.9941905
• DOI: 10.1016/S0145-2126(17)30214-X
• Languages: English
• ISSNs: 0145-2126